epoetin beta [NeoRecormon]
ML20828
Approved small_molecule terminated
Quick answer
epoetin beta [NeoRecormon] for Anemia is a Approved program (small_molecule) at Hoffmann-La Roche with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Hoffmann-La Roche
- Indication
- Anemia
- Phase
- Approved
- Modality
- small_molecule
- Status
- terminated